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Abstract
Occupational exposure to solvents is consistently associated with the risk of systemic sclerosis. We pose the question of whether 
the occupational exposure to anesthetics may favor the occurrence of this disease. This paper describes an incidence of systemic 
sclerosis in the case of an anesthesiologist who had been occupationally exposed to high doses of anesthetic in the operating room. 
Anecdotal cases in the literature give limited support to the causal association of the occupational exposure to anesthetics and 
systemic sclerosis. The extremely limited number of workers exposed makes it necessary to report all cases observed in order to 
assess the degree of the occupational risk for anesthesiologists. Med Pr 2016;67(4):557–560
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Streszczenie
Narażenie zawodowe na rozpuszczalniki jest związane z  ryzykiem wystąpienia sklerodermii. Celem pracy było zbadanie, czy 
narażenie zawodowe na środki znieczulające również może wywołać tę chorobę. W artykule przedstawiono przypadek skleroder-
mii u lekarki anestezjologa, która była narażona na wysokie dawki środków znieczulających na sali operacyjnej. Opublikowane 
dotąd opisy przypadków nie pozwalają jednoznacznie powiązać narażenia zawodowego na środki znieczulające z wystąpieniem 
sklerodermii. Ze względu na niewielką liczbę pracowników narażonych na te środki powinny być raportowane wszystkie przy-
padki wystąpienia sklerodermii w celu określenia stopnia ryzyka zawodowego u anestezjologów. Med. Pr. 2016;67(4):557–560
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INTRODUCTION
Systemic sclerosis or scleroderma (SS) is a rare multisys-
tem disease characteristic of the incidence ranging be-
tween 2–12 cases per year per million people at risk. The 
two main types, limited  (morphea) or diffuse SS, have 
a different evolution and prognosis. In the recent decades 
there has been an increase in the incidence of the disease, 
that has now reached approx. 20 cases per million, main-
ly on account of improvements in diagnostic criteria. 
The disease is characterized by an alteration in microcir-
culation that leads to massive deposition of collagen in 
the connective tissue of various parts of the body, includ-
ing the skin, esophagus, lungs, gastro-intestinal tract, 
the kidneys, heart and some internal organs [1].
The etiology of scleroderma is not clear. Epidemio-
logical data suggests a complex interaction of genetic, 
environmental and hormonal alterations that give rise 
to fibrotic changes. Among occupational factors, suf-
ficient evidence has been collected to establish the asso-
ciation between the occupational exposure to silica and 
scleroderma: a meta-analysis has reported that the risk 
of the  SS has at least tripled among workers exposed 
to silica [2]. Vinyl chloride monomer is another known 
factor in the case of the morphea and the SS [3–5]. More 
recently, the occupational exposure to vinyl acetate has 
also been associated with the onset of the SS and con-
nective tissue disorders [6].
To date, the question that has aroused most concern 
due to the possible association with scleroderma is the 
occupational exposure to solvents. The term solvent in-
cludes a large number of chemicals that are not related 
to one another. For practical and preventive purposes, 
it is important to understand which categories of sol-
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ly with monoclonal antibodies (rituximab  (RTX), 
a  monoclonal antibody  (mAb) against B-lymphocyte 
antigen (CD20)), causing improvement in the skin and 
lung changes. This treatment was followed by the onset 
of diabetes mellitus type  II. Since  2009  she had been 
undergoing treatment with felodipine, acetylsalicylic 
acid, and trometamol. She complained of dysphagia, 
alternating bowel function, gait difficulties for forefoot 
numbness, and shortness of breath on exertion. There 
is no history of digital ulcers.
In July 2008, after a highly undifferentiated tumor 
of the left axillary lymph nodes with occult primary 
had been detected, the subject underwent depletion of 
the armpit, chemotherapy and subsequent radiothera-
py (the last cycle in February 2009). During radiation 
treatment, the patient reported an episode of pleuro-
pericarditis. She had also had episodes of paroxysmal 
tachycardia since 2006. In October 2012 some improve-
ment was obtained by performing ablation.
During a physical examination in December 2014, 
we observed prominence of perioral wrinkles, without 
ongoing digital ulcer disease.
The patient gave an informed consent to the publi-
cation of this paper.
DISCUSSION
The onset of scleroderma has been associated with the 
administration of a  large number of drugs including: 
pentazocine [9], cocaine [10], mepivacaine [11], bleomy-
cin and d-penicillamine  [12], doxorubicin and cyclo-
phosphamide [13]. Some of those drugs are commonly 
used in anesthesiology. The occurrence of a family clus-
ter of dermatomyositis and scleroderma has been as-
sociated with the use of dental anesthetics [14]. These 
studies have a limited interest in our case because an-
esthesiologists are not occupationally exposed to drugs 
that are administered intravenously or intramuscular-
ly. They are, however, occupationally exposed to anes-
thetics administered via inhalation.
Until recently high levels of anesthetic pollution 
in the operating rooms of Italian hospitals have been 
often reported. A  review of studies conducted in the 
late 1980’s showed that pollution during surgery exceed-
ed 1000 ppm of nitrous oxide (against a time weighted 
average threshold limit value  (TLV-TWA) of  50  ppm 
established in  1989), while mixed halogenated ethers 
(halothane, enflurane, isoflurane) often showed levels 
greater than  100  ppm, as compared with a  TLV-TWA 
of 50 ppm [15]. Appreciable concentrations of local an-
vents may be associated with scleroderma. A recent re-
view concludes that the high cumulative exposure to 
aromatic solvents, chlorinated solvents, trichlorethyl-
ene, ketones and white spirit has an impact upon the 
development of the  SS, and the association between 
the SS and the occupational exposure may be variable 
according to gender [7]. A prospective study has recent-
ly shown that occupational cases have the worst prog-
nosis as compared to idiopathic ones. The exposure to 
crystalline silica/solvents is correlated with more severe 
forms of the SS characterized by diffuse cutaneous in-
volvement, interstitial lung disease, general microan-
giopathy (digital ulcers and myocardial dysfunction), 
and association with cancer [8].
Anesthetics consist of a  heterogeneous group of 
substances, all of which have a solvent effect. Our study 
poses the question of whether the occupational expo-
sure to anesthetics may induce the occurrence of sys-
temic sclerosis.
CASE REPORT
A 59-year-old woman was referred to our outpatient oc-
cupational medicine unit to determine the cause of her 
diseases. She was a physician specializing in anesthesia 
and intensive care, and had been working in the operat-
ing theatre of a public hospital since 1980. She reported 
that until 1989 the hospital had been located in a for-
mer convent where halothane and other halogenated 
ethers had been extensively used in the operating the-
aters. The latter had not been equipped with devices for 
the removal of anesthetics, so the surgical staff mem-
bers had been exposed to very high levels of anesthetic 
exposure until at least the mid-90’s. Subsequently the 
environmental situation gradually improved when the 
hospital was transferred to a new building and the use 
of chloro-fluoro-halogenated anesthetics was gradually 
reduced. The subject also reported the occupational ex-
posure to night work, physical agents (ionizing radia-
tion), and biological agents.
In July 2005, she reported the appearance of swell-
ing of the right hand, in result of which she underwent 
surgery. The subsequent onset of paresthesia, edema, 
swelling and Raynaud’s phenomenon in her feet and 
left hand suggested the need for rheumatologic tests 
which documented the presence of anti-nuclear an-
tibody  (ANA) and lupus anti-coagulant  (LAC) anti-
body. A biopsy revealed systemic sclerosis. Chest X-rays 
showed basal bronchiectasis. She was treated with 
prednisone and cyclophosphamide, and subsequent-
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esthetics were also present in adjacent operating rooms 
and side rooms where operating staff members could 
rest. On account of this situation, the Italian Ministry of 
Health decided to issue a circular requiring the adoption 
of standards and controls to evaluate exposure levels and 
limit the duration of occupational exposure  [16]. Over 
the years, the gradual introduction of devices for collect-
ing vapors and the substitution of ethers with less toxic 
products have led to mitigation of that risk.
Halogenated anesthetics share many physical-
chemical and toxicological properties with solvents. 
Epidemiological evidence has shown solvents to be re-
sponsible for the development of scleroderma. Evalua-
tion of causal links is particularly difficult in the case of 
scleroderma. The rarity of the disease restricts applica-
tion of the classical criteria of Bradford-Hill  [17], and 
the limited number of workers exposed to anesthetics 
(about 10 000 anesthesiologists in Italy) hinders epide-
miological investigation. On account of similarities in 
their respective structural formulas and toxicological 
properties, bromo-fluoro-chlorinated anesthetics may 
behave in a way similar to the halogenated aliphatic hy-
drocarbons that are known to cause scleroderma. 
In the case we observed, the subject had been ex-
posed to high doses of anesthetics, especially at the 
beginning of her working career. In this specific case, 
however, the dose was not of particular importance. We 
must remember that the possible triggering of autoim-
mune mechanisms does not necessarily require a spe-
cific threshold, nor is it necessary for the exposure to 
be maintained in order to observe disease progression. 
The time interval between the exposure and the onset 
of clinical signs may be considered reasonably compat-
ible with an occupational etiology. Finally, there is bio-
logical plausibility, even if this is limited by the lack of 
the current knowledge on scleroderma.
The solvents and their reactive metabolites bind co-
valently to proteins, thus stimulating an autoimmune 
reaction  [18]. This general mechanism applies to all 
chemical compounds associated with scleroderma. The 
toxic substances implicated in scleroderma specifically 
induce a  redistribution of nuclear autoantigens, thus 
favoring the presentation of sub-nuclear particles to 
cytoplasmic proteasomes. In other words, the nuclear 
autoantibodies of scleroderma require the intervention 
of a  toxic substance to be processed by the ubiquitin 
proteasome system [19]. Recent studies indicate that the 
cells of the innate immune system, pattern recognition 
receptors, and activation of dendritic cells by chemicals 
play a prominent role in scleroderma [20].
On the basis of the current knowledge on plausible 
causation, we believe that the occupational exposure 
to anesthetics may have caused scleroderma. We have 
drawn attention to the aforementioned case in order to 
encourage the reporting of other similar cases.
An important issue of this case is related to the ap-
pearance of a neoplasm three years after the onset of 
scleroderma. Cancer and autoimmune diseases are 
often associated with scleroderma, and it is difficult 
to determine which is the primary disease. Malignant 
neoplasms may induce a wide variety of paraneoplas-
tic rheumatological syndromes  [21,22]. The opposite 
is also true, as it has been observed that scleroderma 
caused by the occupational exposure to solvents may 
frequently result in cancer  [8]. Recent studies have 
suggested a model of paraneoplastic autoimmunity in 
which cross-reactive immune responses may target au-
toantigens expressed both in cancers and diseased au-
toimmune target tissues [23]. A retrospective study of 
a British cohort of the SS cases has indicated that 7.1% of 
patients had a history of cancer shortly after the onset 
of the SS, with breast cancer being the commonest neo-
plasm [24]. In this case the long latency period required 
for the onset of cancer reduces the likelihood of a para-
neoplastic syndrome and supports the hypothesis that 
both the SS and subsequent cancer have been related to 
the occupational exposure to anesthetics.
CONCLUSIONS
This report highlights the importance of a  comprehen-
sive and detailed collection of occupational exposures for 
patients diagnosed with systemic sclerosis. Only the ob-
servation of a large number of people exposed to solvents 
may help us understand if there is an association between 
the occupational exposure to anesthetics and the SS.
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